| QGIAX | VFINX | QGIAX / VFINX | |
| Total Expense Ratio | 0.74 | 0.14 | 529% |
| Annual Report Gross Expense Ratio | 1.27 | 0.14 | 907% |
| Fund Existence | 35 years | 50 years | - |
| Gain YTD | 10.936 | 12.242 | 89% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 253M | 1.69T | 0% |
| Annual Yield % from dividends | 0.65 | 0.97 | 67% |
| Returns for 1 year | -2.52 | 20.50 | -12% |
| Returns for 3 years | 20.31 | 75.08 | 27% |
| Returns for 5 years | 4.38 | 72.92 | 6% |
| Returns for 10 years | 56.62 | 251.01 | 23% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| RDWU | 8.10 | 0.27 | +3.45% |
| T-REX 2X LONG RDW DAILY TARGET ETF | |||
| PJP | 130.03 | 1.14 | +0.89% |
| Invesco Pharmaceuticals ETF | |||
| IWX | 112.30 | 0.48 | +0.43% |
| iShares Russell Top 200 Value ETF | |||
| SIHY | 45.29 | 0.06 | +0.13% |
| Harbor Ares Systematic High-Yield ETF | |||
| CPHY | 51.81 | 0.05 | +0.09% |
| F/m Compoundr High Yield Bond ETF | |||